Cancer immunology, immunotherapy : CII.

ISSN 0340-7004Springer Science and Business Media Deutschland GmbHGermany
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Journal identity
Titles
Cancer Immunology, Immunotherapy
Cancer Immunol. Immunother. (abbreviated)
Cancer Immunology, Immunotherapy : CII
Cancer Immunol Immunother (abbreviated)
CANCER IMMUNOLOGY IMMUNOTHERAPY SPRINGER
Cancer immunology, immunotherapy : CII.
Key identifiers
ISSN
0340-7004
0340-7004
eISSN
1432-0851
NLM ID
8605732
Publisher / basic metadata
Publisher
Springer Science and Business Media Deutschland GmbH
Springer
Berlin ; New York, NY : Springer International, c1982-
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
1976–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF20255.1Q11961JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
1.805
Best Quartile
Q1
H-index
148
Subject categories
  • Cancer Research — Q1
  • Immunology — Q1
  • Immunology and Allergy — Q1
  • Medicine (miscellaneous) — Q1
  • Oncology — Q1
More metrics
Coverage
1976–2026
Country
Germany
Region
Western Europe
Publisher
Springer Science and Business Media Deutschland GmbH
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
366
Total documents (3 years)
828
Total references
16337
Total citations (3 years)
4563
Citable documents (3 years)
822
Citations per document (2 years)
5.56
References per document
44.64
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1432-0851, 0340-7004
SCImago Source ID
29152
SCImago Rank (across all SCImago source types)
1736

Publication activity

Publication activity
SCImago
2025
366 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC-ND
APC (article processing charge)
3590 EUR; 4790 USD; 2990 GBP
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
No
Preservation services
CLOCKSS, Portico
Added to DOAJ
2024-12-04
Journal homepage
DOAJ profile
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
0340-7004, 1432-0851

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Immunotherapy; Neoplasms/immunology*Neoplasms/therapy
Coverage / history
Scopus:1976-2026
MEDLINE:MEDLINE: v13n1, 1982-; PubMed: v13n1, 1982-; Index medicusIn: PMC;
PubMed:MEDLINE: v13n1, 1982-; PubMed: v13n1, 1982-; Index medicusIn: PMC;
PMC:v.13(1) 1982 – v.75(10) 2026